Umarani Pugazhenthi

1.2k total citations
23 papers, 958 citations indexed

About

Umarani Pugazhenthi is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Small Animals. According to data from OpenAlex, Umarani Pugazhenthi has authored 23 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Small Animals. Recurrent topics in Umarani Pugazhenthi's work include Retinoids in leukemia and cellular processes (6 papers), Diphtheria, Corynebacterium, and Tetanus (5 papers) and Animal testing and alternatives (4 papers). Umarani Pugazhenthi is often cited by papers focused on Retinoids in leukemia and cellular processes (6 papers), Diphtheria, Corynebacterium, and Tetanus (5 papers) and Animal testing and alternatives (4 papers). Umarani Pugazhenthi collaborates with scholars based in United States, Japan and France. Umarani Pugazhenthi's co-authors include Bryan R. Haugen, Joshua Klopper, Rebecca E. Schweppe, Miriam Benezra, Jeffrey A. Knauf, Christopher Korch, John A. Copland, Robert C. Smallridge, James A. Fagin and Laura A. Marlow and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Oncogene and Clinical Cancer Research.

In The Last Decade

Umarani Pugazhenthi

20 papers receiving 949 citations

Peers

Countries citing papers authored by Umarani Pugazhenthi

Since Specialization

Citations

This map shows the geographic impact of Umarani Pugazhenthi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Umarani Pugazhenthi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Umarani Pugazhenthi more than expected).

Fields of papers citing papers by Umarani Pugazhenthi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Umarani Pugazhenthi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Umarani Pugazhenthi. The network helps show where Umarani Pugazhenthi may publish in the future.

Co-authorship network of co-authors of Umarani Pugazhenthi

This figure shows the co-authorship network connecting the top 25 collaborators of Umarani Pugazhenthi. A scholar is included among the top collaborators of Umarani Pugazhenthi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Umarani Pugazhenthi. Umarani Pugazhenthi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Focal adhesion kinase promotes ribosome biogenesis to drive advanced thyroid cancer cell growth and survival 2025 ·Frontiers in Oncology ·M. Kellett, Vibha Sharma, Madeline E. Sherlock, Umarani Pugazhenthi, (unknown), Molishree Joshi, Monika Dzieciątkowska, (unknown), Philip Reigan, Kirk C. Hansen, Jeffrey S. Kieft, Rebecca E. Schweppe	0
2	Fibronectin Contributes to a BRAF Inhibitor–driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2 2023 ·Molecular Cancer Research ·(unknown), Nikita Pozdeyev, Sharon B. Sams, Umarani Pugazhenthi, Elise S. Bales, Marie‐Claude Hofmann, (unknown), Rebecca E. Schweppe	7
3	Antibiotic Treatment of Corynebacterium bovis-associated Clinical Disease in NSG Mice 2023 ·Comparative Medicine ·(unknown), Umarani Pugazhenthi, (unknown), (unknown), (unknown), (unknown), Michael J. Schurr, (unknown)	0
4	A Clinical Scoring Systems for the Evaluation of Corynebacterium bovis -associated Disease in NSG Mice 2022 ·Comparative Medicine ·(unknown), (unknown), Umarani Pugazhenthi, Michael Fink, (unknown), (unknown), (unknown), Michael J. Schurr	1
5	Metaphylactic Antibiotic Treatment to Prevent the Transmission of Corynebacterium bovis to Immunocompromised Mouse Offspring 2020 ·Journal of the American Association for Laboratory Animal Science ·(unknown), Umarani Pugazhenthi, (unknown), Derek Smith, (unknown), (unknown), Michael Fink, (unknown), Michael J. Schurr, (unknown)	5
6	Diagnosis, Surveillance and Management of Streptococcus equi subspecies zooepidemicus Infections in Chinchillas (Chinchilla lanigera) 2020 ·Comparative Medicine ·(unknown), Linda K. Johnson, Marcus J Crim, Charles E. Wiedmeyer, Umarani Pugazhenthi, (unknown), Daniel J. Tollin, (unknown), (unknown), (unknown), (unknown), (unknown)	7
7	Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers 2019 ·Molecular Cancer Research ·Rebecca E. Schweppe, Nikita Pozdeyev, Laura A. Pike, Christopher Korch, Qiong Zhou, Sharon B. Sams, Vibha Sharma, Umarani Pugazhenthi, Christopher D. Raeburn, Maria Albuja‐Cruz, Philip Reigan, Daniel V. LaBarbera, Iñigo Landa, Jeffrey A. Knauf, James A. Fagin, Bryan R. Haugen	12
8	Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis 2018 ·Oncogene ·(unknown), (unknown), M. Kellett, (unknown), Umarani Pugazhenthi, Nikita Pozdeyev, Jihye Kim, Aik Choon Tan, Rebecca E. Schweppe	16
9	Procedure for Horizontal Transfer of Patient-Derived Xenograft Tumors to Eliminate Corynebacterium bovis. 2017 ·PubMed ·(unknown), Stacey M. Bagby, (unknown), Umarani Pugazhenthi, Todd M. Pitts, Stephen B. Keysar, John J. Arcaroli, (unknown)	6
10	Surveillance of a Ventilated Rack System for Corynebacterium bovis by Sampling Exhaust-Air Manifolds. 2016 ·PubMed ·(unknown), Umarani Pugazhenthi, (unknown)	25
11	A rexinoid antagonist increases the hypothalamic–pituitary–thyroid set point in mice and thyrotrope cells 2011 ·Molecular and Cellular Endocrinology ·(unknown), Vibha Sharma, Umarani Pugazhenthi, Celia D. Sladek, William M. Wood, Bryan R. Haugen	16
12	Anti-inflammatory action of exendin-4 in human islets is enhanced by phosphodiesterase inhibitors: potential therapeutic benefits in diabetic patients 2010 ·Diabetologia ·Umarani Pugazhenthi, Kalpana Velmurugan, Anna H. Tran, (unknown), Subbiah Pugazhenthi	57
13	Retinoid and thiazolidinedione therapies in melanoma: an analysis of differential response based on nuclear hormone receptor expression 2009 ·Molecular Cancer ·Joshua Klopper, Vibha Sharma, (unknown), (unknown), (unknown), Umarani Pugazhenthi, Sherif Said, Bryan R. Haugen	19
14	Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification 2008 ·The Journal of Clinical Endocrinology & Metabolism ·Rebecca E. Schweppe, Joshua Klopper, Christopher Korch, Umarani Pugazhenthi, Miriam Benezra, Jeffrey A. Knauf, James A. Fagin, Laura A. Marlow, John A. Copland, Robert C. Smallridge, Bryan R. Haugen	490
15	Effects of Rexinoids on Thyrotrope Function and the Hypothalamic-Pituitary-Thyroid Axis 2005 ·Endocrinology ·Vibha Sharma, (unknown), William M. Wood, Umarani Pugazhenthi, Donald L. St. Germain, Antônio C. Bianco, Wojciech Krężel, Pierre Chambon, Bryan R. Haugen	36
16	Retinoic Acid and Retinoid X Receptors Are Differentially Expressed in Thyroid Cancer and Thyroid Carcinoma Cell Lines and Predict Response to Treatment with Retinoids 2004 ·The Journal of Clinical Endocrinology & Metabolism ·Bryan R. Haugen, (unknown), Umarani Pugazhenthi, (unknown), Joshua Klopper, (unknown), Vibha Sharma	90
17	Quantitative Analysis of Telomerase hTERT mRNA and Telomerase Activity in Endometrioid Adenocarcinoma and in Normal Endometrium 2002 ·Gynecologic Oncology ·Rainer Lehner, Takayuki Enomoto, James McGregor, A. Laurie Shroyer, Bryan R. Haugen, Umarani Pugazhenthi, Kenneth R. Shroyer	43
18	Correlation of survivin mRNA detection with histologic diagnosis in normal endometrium and endometrial carcinoma 2002 ·Acta Obstetricia Et Gynecologica Scandinavica ·Rainer Lehner, Takayuki Enomoto, James McGregor, A. Laurie Shroyer, Bryan R. Haugen, Umarani Pugazhenthi, Kenneth R. Shroyer	32
19	Correlation of survivin mRNA detection with histologic diagnosis in normal endometrium and endometrial carcinoma 2002 ·Acta Obstetricia Et Gynecologica Scandinavica ·Rainer Lehner, Takayuki Enomoto, (unknown), A. Laurie Shroyer, (unknown), Umarani Pugazhenthi, (unknown)	3
20	Snapshot of an enzyme reaction intermediate in the structure of the ATP–Mg2+–oxalate ternary complex of Escherichia coli PEP carboxykinase 1996 ·Nature Structural & Molecular Biology ·Leslie W. Tari, Allan Matte, Umarani Pugazhenthi, Hughes Goldie, Louis T. J. Delbaere	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact